Related Experiment Video
Updated: Aug 10, 2026
06:47
One-step Protocol for Evaluation of the Mode of Radiation-induced Clonogenic Cell Death by Fluorescence Microscopy
Published on: October 23, 2017
Radiation safety when a patient dies after therapy
B Bybel1, M Blais, R Vandierendonck
1Department of Nuclear Medicine, London Health Sciences Centre, Ontario, Canada.
Journal of Nuclear Medicine Technology
|October 2, 1998
Summary
When a patient dies shortly after radionuclide therapy, managing public protection and societal values becomes crucial. This case highlights the complexities of shifting responsibility from patient care after high-dose Iodine-131 treatment for thyroid cancer.
Area of Science:
- Nuclear medicine
- Medical physics
- Oncology
Background:
- Radionuclide therapy involves administering radioactive isotopes for medical treatment.
- High therapeutic doses, such as Iodine-131 (131I), are used for conditions like metastatic thyroid cancer.
- Patient death post-therapy necessitates a transition in responsibility from patient care to public safety.
Observation:
- A specific case involved a patient who died shortly after receiving a large therapeutic dose of 131I for metastatic thyroid cancer.
- This situation raised immediate concerns regarding the safe handling of radioactive remains and public exposure.
- Societal values and funeral rites presented unique challenges in managing the deceased patient's radioactive material.
Findings:
- The case underscored the critical need for clear protocols addressing the shift in accountability from patient care to public health protection.
- Ethical considerations regarding the deceased patient and their family, alongside public safety, must be carefully balanced.
- Anticipated changes in regulatory frameworks for handling radioactive deceased individuals require proactive institutional planning.
Implications:
- Institutions must develop robust guidelines for managing patients undergoing high-dose radionuclide therapy, including end-of-life scenarios.
- Interdisciplinary collaboration among nuclear medicine physicians, radiation safety officers, ethicists, and regulatory bodies is essential.
- Proactive adaptation to evolving regulatory constraints will ensure continued safe practices in radionuclide therapy and post-mortem management.
Related Concept Videos
03:23Types of Radioactivity
The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
01:28Isotopes and Radioisotopes
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...
An isotope containing more...
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...